
Closed
Biomed Propulsion Program
Life sciences financing for Quebec growth companies
Offered by
Investissement Québec (IQ)
Record updated
- Funding available
- $ 500,000 - $ 10,000,000
- Up to 50% of project cost
- Deadline
- Unspecified
- Location
- Quebec, Canada
Overview
Participating loans of up to $10 million support Quebec life sciences companies with strong growth potential. The program helps finance research commercialization, product development, R&D, and medical technology commercialization.
At a glance
Funding available
- Maximum funding
- $10,000,000
- Minimum funding
- $500,000
- Maximum share of project costs
- 50%
- Develop a new product or service
- Conduct research and development activities
- Launch or market a product/service
Eligible candidates
- Location
- Quebec
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- Startups
- Legal structures
- For-profit business
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2025
Periods: 1
Eligibility
Who is eligible?
- For-profit life sciences companies
- Biotechnology companies in human or animal health
- Medical technology companies
Who is not eligible
- Medical, dental, optical, orthotic, prosthetic, and clinical laboratories
- Medical equipment distributors and companies focused only on commercialization
- Consumer-only digital health and health ICT companies
- Cannabis-related businesses outside Health Canada-approved pharmaceutical-grade products or ingredients
Eligible geographic areas
- Quebec
Activities funded
- Commercialization of research results in the life sciences sector.
- Research and development in biotechnology.
- Development of life sciences products, platforms, or processes.
- Design, development, manufacturing, and commercialization of medical devices and medical software.
How to apply
- Step 1: Prepare the financing round
- Obtain a duly accepted shareholders' agreement or subscription agreement.
- Step 2: Send the accepted agreement to Investissement Québec
- Admissibility analysis starts upon receipt of the agreement.
Documents Needed
- Accepted shareholders' agreement or subscription agreement for the financing round
Processing and Agreement
- Admissibility review starts when the accepted shareholders' or subscription agreement is received.
- New applications are currently suspended until further notice.
Additional information
- The program was interrupted on November 12, 2024.
- Investissement Québec has suspended new applications until further notice.
Frequently Asked Questions about the Biomed Propulsion Program Program
What is the Biomed Propulsion Program?
Participating loans of up to $10 million support Quebec life sciences companies with strong growth potential. The program helps finance research commercialization, product development, R&D, and medical technology commercialization.
How much funding can be received?
Biomed Propulsion Program Funds up to 50% of admissible expenses, capped at $10,000,000 per project.
Who is eligible for the Biomed Propulsion Program program?
To be eligible for the Biomed Propulsion Program program, you must:
For-profit life sciences company
Head office and most jobs in Quebec
Private financing required
Who can I contact for more information about the Biomed Propulsion Program?
You can contact Investissement Québec (IQ).
Where is the Biomed Propulsion Program available?
The Biomed Propulsion Program program is available the province of Quebec.
Is the Biomed Propulsion Program a grant, loan, or tax credit?
Biomed Propulsion Program is a Loans and Capital investments
Who are the financial supporters of the Biomed Propulsion Program?
Biomed Propulsion Program is funded by Investissement Québec (IQ)
